United Therapeutics Corporation ( UTHR) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole was unchanged today. By the end of trading, United Therapeutics Corporation fell 53 cents (-1.3%) to $42.02 on light volume. Throughout the day, 971,088 shares of United Therapeutics Corporation exchanged hands as compared to its average daily volume of 1.8 million shares. The stock ranged in price between $41.32-$43.60 after having opened the day at $42.77 as compared to the previous trading day's close of $42.55. Other company's within the Health Care sector that declined today were: China Sky One Medical Inc ( CSKI), down 15.7%, Medgenics Inc ( MDGN), down 15.7%, Vermillion Inc ( VRML), down 15.2%, and Pressure BioSciences Inc ( PBIO), down 14.3%. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. United Therapeutics Corporation has a market cap of $2.52 billion and is part of the drugs industry. The company has a P/E ratio of 14.7, above the average drugs industry P/E ratio of 14.5 and below the S&P 500 P/E ratio of 17.7. Shares are down 32.7% year to date as of the close of trading on Wednesday. TheStreet Ratings rates United as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow.